Biocon Ltd.
BSE: 532523 | Sector: Health care |
NSE: BIOCON | ISIN Code: INE376G01013 |
BSE 10:28 | 25 Feb | 396.25 |
6.35 (1.63%) |
OPEN
396.45 |
HIGH
396.60 |
LOW
390.95 |
NSE 10:09 | 25 Feb | 394.60 |
5.10 (1.31%) |
OPEN
391.70 |
HIGH
395.30 |
LOW
390.55 |
OPEN | 396.45 |
PREVIOUS CLOSE | 389.90 |
VOLUME | 60445 |
52-Week high | 487.70 |
52-Week low | 235.80 |
P/E | 161.08 |
Mkt Cap.(Rs cr) | 47,550 |
Buy Price | 396.05 |
Buy Qty | 200.00 |
Sell Price | 396.35 |
Sell Qty | 50.00 |
Biocon Ltd. (BIOCON) - Peer Group
COMPANY | PRICE (In Rs) |
CHG (%) |
MKT CAP (Rs Cr) |
SALES (Rs Cr) |
PROFIT (Rs Cr) |
EPS (Rs) |
P/E (x) |
Sun Pharma.Inds. | 615.00 | 2.07 | 147556.95 | 8836.78 | 1918.11 | 12.37 | 49.72 |
Divi's Lab. | 3502.60 | 0.56 | 92976.52 | 1701.44 | 470.62 | 70.01 | 50.03 |
Dr Reddy's Labs | 4572.65 | 2.95 | 76043.17 | 4941.90 | 27.90 | 142.98 | 31.98 |
Cipla | 804.80 | 1.93 | 64903.09 | 5168.69 | 752.51 | 32.98 | 24.40 |
Aurobindo Pharma | 867.45 | 0.61 | 50823.90 | 6364.91 | 2946.32 | 50.89 | 17.05 |
Biocon | 396.25 | 1.63 | 47550.00 | 1851.00 | 186.60 | 2.46 | 161.08 |
Lupin | 1032.00 | 2.42 | 46811.52 | 4017.36 | 441.35 | 25.74 | 40.09 |
Cadila Health. | 441.95 | 1.86 | 45242.42 | 3795.60 | 512.50 | 17.62 | 25.08 |
Piramal Enterp. | 1961.05 | 5.50 | 44231.48 | 3168.61 | 799.39 | 0.00 | - |
Torrent Pharma. | 2499.45 | 0.93 | 42295.69 | 1995.00 | 297.00 | 60.69 | 41.18 |
Gland Pharma | 2396.10 | 1.23 | 39176.24 | 859.42 | 204.11 | 56.96 | 42.07 |
Alkem Lab | 2739.10 | -0.95 | 32745.94 | 2318.05 | 463.85 | 133.28 | 20.55 |
Abbott India | 14350.00 | -1.59 | 30493.75 | 1095.37 | 177.14 | 305.50 | 46.97 |
Glaxosmi. Pharma | 1468.45 | 0.90 | 24877.01 | 857.20 | 156.51 | 29.89 | 49.13 |
Ipca Labs. | 1873.80 | 0.31 | 23769.15 | 1409.83 | 267.56 | 88.06 | 21.28 |
Quick Links for Biocon:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices